Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin vs Clonazepam for Idiopathic REM Sleep Behavior Disorder
NCT03255642Completed
- Sponsor
- Kyung Hee University Hospital
- Start
- Nov 2017
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of melatonin in REM sleep behavior disorder (RBD) (2 arms), sponsored by Kyung Hee University Hospital. Primary endpoint: Automated REM without atonia index at 4 weeks. Started Nov 2017; status: completed.
02
Drugs
melatonin
03
Conditions
REM sleep behavior disorder (RBD)
Beyond the preview
Go deeper on NCT03255642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03255642.